ALDX logo

Aldeyra Therapeutics (ALDX) Cash From Investing

Annual CFI

-$44.92 M
-$74.92 M-249.72%

December 1, 2024


Summary


Performance

ALDX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALDXcash flowmetrics:

Quarterly CFI

-$1.56 M
-$6.83 M-129.72%

December 1, 2024


Summary


Performance

ALDX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALDXcash flowmetrics:

TTM CFI

-$44.92 M
-$1.56 M-3.61%

December 1, 2024


Summary


Performance

ALDX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALDXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ALDX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-249.7%-100.0%-249.7%
3 y3 years-10000.0%-100.0%-10000.0%
5 y5 years-343.1%+63.5%-343.1%

ALDX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-249.7%at low-105.2%+97.3%-159.1%+40.9%
5 y5-year-249.7%at low-105.2%+97.3%-159.1%+40.9%
alltimeall time-249.7%at low-105.2%+97.3%-159.1%+40.9%

Aldeyra Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$44.92 M(-249.7%)
-$1.56 M(-129.7%)
-$44.92 M(+3.6%)
Sep 2024
-
$5.26 M(-128.9%)
-$43.35 M(-10.8%)
Jun 2024
-
-$18.24 M(-40.0%)
-$48.61 M(+60.0%)
Mar 2024
-
-$30.38 M(<-9900.0%)
-$30.38 M(-201.3%)
Dec 2023
$30.00 M(-200.2%)
$0.00(0.0%)
$30.00 M(-47.4%)
Sep 2023
-
$0.00(0.0%)
$57.00 M(-25.0%)
Jun 2023
-
$0.00(-100.0%)
$76.02 M(+30.9%)
Mar 2023
-
$30.00 M(+11.1%)
$58.08 M(-293.9%)
Dec 2022
-$29.95 M(>+9900.0%)
$27.00 M(+42.0%)
-$29.95 M(-47.4%)
Sep 2022
-
$19.02 M(-206.0%)
-$56.95 M(-25.0%)
Jun 2022
-
-$17.94 M(-69.1%)
-$75.97 M(+30.9%)
Mar 2022
-
-$58.03 M(<-9900.0%)
-$58.03 M(>+9900.0%)
Dec 2021
-$7800.00(-100.0%)
$0.00(0.0%)
-$7800.00(0.0%)
Sep 2021
-
$0.00(0.0%)
-$7800.00(-100.1%)
Jun 2021
-
$0.00(-100.0%)
$5.49 M(-75.9%)
Mar 2021
-
-$7800.00(<-9900.0%)
$22.79 M(-21.5%)
Dec 2020
$29.02 M(+57.1%)
$0.00(-100.0%)
$29.02 M(+17.3%)
Sep 2020
-
$5.50 M(-68.2%)
$24.74 M(-0.7%)
Jun 2020
-
$17.30 M(+178.0%)
$24.91 M(+60.4%)
Mar 2020
-
$6.22 M(-245.2%)
$15.54 M(-15.9%)
Dec 2019
$18.48 M(-179.2%)
-$4.29 M(-175.5%)
$18.48 M(-397.5%)
Sep 2019
-
$5.68 M(-28.4%)
-$6.21 M(-47.8%)
Jun 2019
-
$7.92 M(-13.6%)
-$11.91 M(-37.2%)
Mar 2019
-
$9.16 M(-131.6%)
-$18.97 M(-18.7%)
DateAnnualQuarterlyTTM
Dec 2018
-$23.34 M(+128.8%)
-$28.97 M(>+9900.0%)
-$23.34 M(+843.5%)
Sep 2018
-
-$21.30 K(-102.5%)
-$2.47 M(-59.3%)
Jun 2018
-
$856.60 K(-82.2%)
-$6.08 M(-3.3%)
Mar 2018
-
$4.80 M(-159.2%)
-$6.29 M(-38.3%)
Dec 2017
-$10.20 M(+4428.3%)
-$8.11 M(+123.5%)
-$10.20 M(+1227.9%)
Sep 2017
-
-$3.63 M(-659.4%)
-$768.00 K(-122.4%)
Jun 2017
-
$648.50 K(-27.3%)
$3.43 M(+407.3%)
Mar 2017
-
$891.50 K(-32.5%)
$675.50 K(-400.0%)
Dec 2016
-$225.20 K(-98.3%)
$1.32 M(+132.9%)
-$225.20 K(-98.4%)
Sep 2016
-
$566.70 K(-127.0%)
-$14.50 M(-4.1%)
Jun 2016
-
-$2.10 M(>+9900.0%)
-$15.12 M(+15.9%)
Mar 2016
-
-$9200.00(-99.9%)
-$13.04 M(+0.1%)
Dec 2015
-$13.04 M(>+9900.0%)
-$12.95 M(>+9900.0%)
-$13.04 M(>+9900.0%)
Sep 2015
-
-$54.20 K(+78.3%)
-$94.00 K(+104.8%)
Jun 2015
-
-$30.40 K(+2071.4%)
-$45.90 K(+196.1%)
Mar 2015
-
-$1400.00(-82.5%)
-$15.50 K(+9.9%)
Dec 2014
-$14.10 K(<-9900.0%)
-$8000.00(+31.1%)
-$14.10 K(+131.1%)
Sep 2014
-
-$6100.00(<-9900.0%)
-$6100.00(<-9900.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00
$0.00
Dec 2012
$0.00(0.0%)
-
-
Dec 2011
$0.00
-
-

FAQ

  • What is Aldeyra Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Aldeyra Therapeutics?
  • What is Aldeyra Therapeutics annual CFI year-on-year change?
  • What is Aldeyra Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Aldeyra Therapeutics?
  • What is Aldeyra Therapeutics quarterly CFI year-on-year change?
  • What is Aldeyra Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Aldeyra Therapeutics?
  • What is Aldeyra Therapeutics TTM CFI year-on-year change?

What is Aldeyra Therapeutics annual cash flow from investing activities?

The current annual CFI of ALDX is -$44.92 M

What is the all time high annual CFI for Aldeyra Therapeutics?

Aldeyra Therapeutics all-time high annual cash flow from investing activities is $30.00 M

What is Aldeyra Therapeutics annual CFI year-on-year change?

Over the past year, ALDX annual cash flow from investing activities has changed by -$74.92 M (-249.72%)

What is Aldeyra Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of ALDX is -$1.56 M

What is the all time high quarterly CFI for Aldeyra Therapeutics?

Aldeyra Therapeutics all-time high quarterly cash flow from investing activities is $30.00 M

What is Aldeyra Therapeutics quarterly CFI year-on-year change?

Over the past year, ALDX quarterly cash flow from investing activities has changed by -$1.56 M (-100.00%)

What is Aldeyra Therapeutics TTM cash flow from investing activities?

The current TTM CFI of ALDX is -$44.92 M

What is the all time high TTM CFI for Aldeyra Therapeutics?

Aldeyra Therapeutics all-time high TTM cash flow from investing activities is $76.02 M

What is Aldeyra Therapeutics TTM CFI year-on-year change?

Over the past year, ALDX TTM cash flow from investing activities has changed by -$74.92 M (-249.72%)